Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases : a European multicenter cohort study
Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt) · 01.01.2026
DOI: 10.25673/124461 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt), erschienen am 01.01.2026. Verfasst von Sebastian Schäfer und 30 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Metastasis-directed radiotherapy is of increasing importance in the multidisciplinary management of oligometastatic non-small cell lung cancer (NSCLC), but outcome patterns for stereotactic body radiotherapy (SBRT) of bone oligometastases (BoM) remain insufficiently defined. We aimed to determine oncological outcomes and prognostic factors of SBRT for BoM of NSCLC. Materials and methods Patients with NSCLC treated with SBRT for < 5 BoM between 2010 and 2024 at 15 European cancer centers were retrospectively analyzed. Outcomes included freedom from local recurrence (FFLR), progression-free survival (PFS), overall survival (OS), and adverse events.
Results
With a median follow-up of 14 months (IQR: 7–24 months), 85 patients with 111 treated BoM were analyzed. The 2-year FFLR was 87.2% (95%-CI: 73.3%-94.1%). The 1-/2-year PFS for singular BoM was 60.1% (CI: 44.6%-72.5%)/ 39.9% (CI: 24.6%-54.8%), while for 2–3 BoM they amounted to 10.2% (95%-CI: 0.6%-35.8%) and 0%. In multivariable analysis, less favorable outcome for OS and PFS was associated with larger BoM (HR 1.003; p < 0.01 and HR 1.005, p < 0.001) and increased number of treated BoM (HR 1.72; p = 0.03 and HR 1.93; p < 0.01). Treatment was well tolerated, with fracture rates of 5.4% and no grade 4 and 5 adverse events.
Conclusion
This multicenter cohort analysis revealed that SBRT of BoM from NSCLC appears to be an effective and well-tolerated treatment. Presence of singular BoM was a favorable prognostic factor. Prospective studies are needed to confirm these findings and to determine the role of SBRT in the multidisciplinary management of oligometastases.
Schlagwörter
Zitieren
APA
Schäfer, S., Seiler, I., Balermpas, P., Wachter, C. V., Loi, M., Greto, D., Schunn, A. S., Drabke, S., Klischies, K., Wittenstein, O., Willner, J., Lohaus, F., Kästner, L., Meents, J., Bank, P., Slavik, M., Burkon, P., Partl, R., Müller, J. A., …, & Nägler, F. (2026). Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases : a European multicenter cohort study. Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt). https://doi.org/10.25673/124461
Vancouver
Schäfer S, Seiler I, Balermpas P, Wachter CV, Loi M, Greto D, et al. Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases : a European multicenter cohort study. Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt). 2026. doi:10.25673/124461
BibTeX
@article{Schfer2026,
author = {Schäfer, Sebastian and Seiler, Isabell and Balermpas, Panagiotis and Wachter, Camilla von and Loi, Mauro and Greto, Daniela and Schunn, Anna Sabrina and Drabke, Sophia and Klischies, Kenneth and Wittenstein, Olaf and Willner, Jochen and Lohaus, Fabian and Kästner, Lena and Meents, Johannes and Bank, Priska and Slavik, Marek and Burkon, Petr and Partl, Richard and Müller, Jörg Andreas and Dzierma, Yvonne and Mader, Thomas and Trommer, Maike and Gkika, Eleni and Rühle, Alexander and Guckenberger, Matthias and Moustakis, Christos and Brunner, Thomas and Blanck, Oliver and Boda-Heggemann, Judit and Nicolay, Nils H. and Nägler, Franziska},
title = {Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases : a European multicenter cohort study},
journal = {Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt)},
year = {2026},
doi = {10.25673/124461}
}
EUVIMED